Journal of Autism and Developmental Disorders

, Volume 23, Issue 1, pp 193–199 | Cite as

Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium

  • Lelland Tolbert
  • Ted Haigler
  • Mary Margaret Waits
  • Troy Dennis
Brief Reports

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barber, G. & Spaeth, G. (1969). The successful treatment of homocystinuria with pyridoxine.Journal of Pediatrics, 75, 463–474.Google Scholar
  2. Bendich, A., & Cohen, M. (1990). Vitamin B6 safety issues.Annals of the New York Academy of Science, 585, 321–337.Google Scholar
  3. Cohen, M. & Bendich, A. (1986). Safety of pyridoxine—A review of human and animal studies.Toxicology Letters, 34, 129–146.Google Scholar
  4. Freeman, B. J., Ritvo, E. R., Yokota, A., & Ritvo, A. (1986). A scale for rating symptoms of patients with the syndrome of autism in real life settings.Journal of the American Academy of Child Psychiatry, 25, 130–136.Google Scholar
  5. Gerger, A. & Schaumburg, A. (1984). More on neuropathy from pyridoxine abuse.New England Journal of Medicine, 311, 986–988.Google Scholar
  6. Gill, H. S., & Rose, G. A. (1986). Mild metabolic hyperoxaluria and its response to pyridoxine.Urology International, 41, 393–396.Google Scholar
  7. Kasdan, M. L., & Janes, C. (1987). Carpal tunnel syndrome and vitamin B6.Plastic and Reconstructive Surgery, 79, 456–466.Google Scholar
  8. Lelord, G., Callaway, E. & Much, J. P., (1982). Clinical and biological effects of high doses of Vitamin B6 and magnesium on autistic children.Acta Vitaminology and Enzymology, 4, 27–36.Google Scholar
  9. Lelord, G., Much, J. P., Barthélémy, C., Martineau, J. & Garreau, B. (1981). Effects of pyridoxine and magnesium on autistic symptoms—initial observations.Journal of Autism and Developmental Disorders, 11, 219–223.Google Scholar
  10. Martineau, J., Barthélémy, C., Chelickine, C., & Lelord, G. (1988). Brief Report: An open middle term study of combined Vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment.Journal of Autism and Developmental Disorders, 18, 435–443.Google Scholar
  11. Martineau, J., Barthélémy, C., Garreau, B., & Lelord, G. (1985). Vitamin B6, magnesium, and combined B6−Mg: Therapeutic effects of childhood autism.Biological Psychiatry, 20, 467–473.Google Scholar
  12. Martineau, J., Barthélémy, C. & Lelord, G. (1986). Long-term effects of combined Vitamin B6-magnesium administration in an autistic child.Biological Psychiatry, 21, 511–519.Google Scholar
  13. Martineau, J., Barthélémy, C., Roux, S., Garreau, B., & Lelord, G. (1989). Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behavior.Developmental Medicine and Childhood Neurology, 31, 721–726.Google Scholar
  14. Martineau, J., Garreau, B., Barthélémy, C., Callaway, E., & Lelord, G. (1981). Effects of vitamin B6 on average evoked potentials in infantile autism.Biological Psychiatry, 16, 627–635.Google Scholar
  15. O'Brien, P. M. S. (1982). The premenstrual syndrome: A review of the present status of therapy.Drugs, 24, 140–161.Google Scholar
  16. Pettit, R. E. (1987). Pyridoxine dependency seizures: Report of a case with unusual features.Journal of Childhood Neurology, 2, 38–41.Google Scholar
  17. Rimland, B. (1973). High dosage levels of certain vitamins in the treatment of children with severe mental disorders. In D. Hawkins & L. Pauling (Eds.),Orthomolecular psychiatry. San Francisco: W. H. Freeman.Google Scholar
  18. Rimland, B., Callaway, E., & Dreyfuss, P. (1978). The effects of high doses of vitamin B6 on autistic children: A double-blind cross-over study.American Journal of Psychiatry, 135, 472–478.Google Scholar
  19. Schaumburg, H., Kaplan, J., Windebank, A., Vick, N., Rasmus, S., Pleasure, D., & Brown, M. J. (1983). Sensory neuropathy from pyridoxine.New England Journal of Medicine, 309, 445–447.Google Scholar

Copyright information

© Plenum Publishing Corporation 1993

Authors and Affiliations

  • Lelland Tolbert
    • 1
    • 2
  • Ted Haigler
    • 1
    • 2
  • Mary Margaret Waits
    • 1
    • 2
  • Troy Dennis
    • 1
    • 2
  1. 1.Department of Psychiatry and Behavioral NeurobiologyUniversity of Alabama at Birmingham, UAB StationBirminghamUSA
  2. 2.Glenwood Mental Health Services, IncGlenwoodUSA

Personalised recommendations